You are here

Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Genk, , 3600 Belgium
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Osteoarthritis, Rheumatoid Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects with a clinical diagnosis of OA or RA and who are expected to require regular
anti-inflammatory therapy for arthritis symptom management

- Subjects must be aged 60 years or older with or without a history of gastroduodenal
(GD) ulceration; or be of any age 18 years or older and have had documented evidence
of GD ulceration 90 days or more prior to the screening visit

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Active GD ulceration or GD ulceration within 90 days of the screening visit.

- Concomitant use of low dose aspirin

- Previous MI, stroke or significant vascular disease.

NCT00141102
Pfizer
Completed
Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now